The Asia-Pacific pharmaceutical analytical testing outsourcing market is projected to grow at a CAGR of around 9.5% during the forecast period (2021-2027). The rising number of clinical trials in various economies such as India, China, Japan, and others provide a significant opportunity to the pharmaceutical analytical testing outsourcing market in the region. As per the WHO, China accounted for the highest clinical trials around 31.1 thousand between 2015 and 2019. Cohesive government policies will benefit cardiac safety services since the Chinese government has a series of policies to eliminate the pharmaceutical innovation gap between China and other leading countries. These policies include developing the multinational clinical centers, accelerating the approval process of special medicines, sharing clinical data around the globe, and enhancing the protection of clinical data, among others.
Browse the full report description of "Asia-Pacific Pharmaceutical Analytical Testing Outsourcing Market Size, Share & Trends Analysis Report by Product Type (API, Raw Materials, and Finished products), By Services (Bioanalytical services, Stability testing, Drug substance, Method development & Validation, and Others) and Forecast 2021-2027" at https://www.omrglobal.com/industry-reports/asia-pacific-pharmaceutical-analytical-testing-outsourcing-market
Moreover, rising pharmaceutical outsourcing services in emerging economies such as China, India, and others further provide a significant opportunity for the market. The shift of outsourcing pharmaceutical services towards Asia-pacific economies such as China and India from the US further propels the market. The shifts are experienced due to the presence of many skilled contract manufacturers and the presence of inexpensive labor in the Asia-pacific region. Another major factor that is attracting foreign investments in the Indian pharmaceutical sector is the increasing balance of trade in the pharma sector. The investment in the drug and pharmaceuticals sector will significantly shift the focus of pharmaceuticals companies into the Asia-Pacific market that further increase the demand for pharmaceutical analytical testing outsourcing services in the region.
Market Coverage
|
Report Elements |
Details |
|
Study Period |
2020-2027 |
|
Base year |
2020 |
|
Forecast period |
2021-2027 |
|
Segments Covered |
By Product Type and by Services |
|
Regions Covered |
China, India, Japan, and the Rest of Asia-Pacific |
|
Key Companies Profiled |
Charles
River Laboratories International, Inc., CMIC, Inc, Cambrex Corp., Covance
Inc., Dalton Pharma Services, WuXi AppTec Co., Ltd., and others |
Key questions addressed by the report
o Recovery Timeline
o Deviation from the pre-COVID-19 forecast
o Most affected region/segment
o Recommendations
Asia-Pacific Pharmaceutical Analytical Testing Outsourcing Market – Segmentation
By Product type
By Services
Asia-Pacific Pharmaceutical Analytical Testing Outsourcing Market – Segmentation by Geography
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/asia-pacific-pharmaceutical-analytical-testing-outsourcing-market